Knop, S <br/><br/>
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma.  [electronic resource] 

 -  Leukemia  08 2017 
 - 1816-1819 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2017.124  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Induction Chemotherapy<br/>Lenalidomide<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Survival Analysis<br/>Thalidomide--administration & dosage<br/>Young Adult